A detailed history of Catalyst Funds Management Pty LTD transactions in Bio Techne Corp stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 4,700 shares of TECH stock, worth $295,865. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,700
Holding current value
$295,865
% of portfolio
0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$58.47 - $78.75 $274,809 - $370,125
4,700 New
4,700 $276 Million
Q1 2024

Dec 04, 2024

BUY
$65.98 - $77.09 $26,392 - $30,836
400 New
400 $28.2 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.47B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Catalyst Funds Management Pty LTD Portfolio

Follow Catalyst Funds Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Funds Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Funds Management Pty LTD with notifications on news.